Home Stomach Ulcer Test Kits segmentation by application separates the market into diagnostic, screening, and monitoring uses. The diagnostic segment, accounting for roughly 55 % of total sales, involves kits employed by consumers after symptom onset to confirm the presence of Helicobacter pylori or ulcer‑related biomarkers; its size is driven by high prevalence of acute dyspepsia and the growing preference for point‑of‑care confirmation. The screening segment, representing about 30 % of the market, targets asymptomatic individuals in high‑risk populations (e.g., smokers, NSAID users) and is expanding due to public‑health campaigns promoting early detection. The monitoring segment, contributing the remaining 15 %, includes kits used for post‑treatment verification and long‑term surveillance, a niche that benefits from repeat‑purchase cycles and adherence programs. Collectively, these application categories shape the overall market size, with diagnostic demand providing the base, screening adding growth potential, and monitoring ensuring recurring revenue streams.